Literature DB >> 15755263

Lessons from the English smoking treatment services.

Martin Raw1, Ann McNeill, Tim Coleman.   

Abstract

This paper summarizes and discusses the key findings of the evaluation of the English smoking treatment services, which were established in 1999 as part of the English National Health Service. Within 4 years these services existed throughout the country and were working at full capacity, a total of pound 76 million having been spent on them over this period, excluding medication costs. In the fourth year almost 235,000 people attended treatment and set a quit date, and the total budget, including medications, was approximately pound 50 million. At the end of the fourth year the government allocated pound 138 million for the services for the period April 2003-March 2006. The CO-validated 4-week abstinence rate was 53%, the validated 52-week abstinence rate was 15%, and the relapse rate from 4 to 52 weeks was 75%. There was no sex difference in cessation rates at long-term follow-up. The cessation results and relapse rate from weeks 4 to 52 are consistent with results from published studies, including clinical trials. The estimated cost per life-year saved was pound 684 and the figure is even lower if the potential future health care cost savings are taken into account at pound 438 per life-year saved. This compares with the benchmark of pound 20,000 per life-year saved, which the National Institute for Clinical Excellence (NICE) is using to recommend new health care interventions in the National Health Service. The services were also succeeding in reaching disadvantaged smokers. However, there have been problems, and other health care systems considering an initiative of this kind should: set national training standards and increase training capacity before launching the services; standardize the provision of pharmaceutical treatments and make them as accessible as possible before launching the services; and give the services at least 5 years of central funding to allow them to become well established. Monitoring is extremely important but should not be so much of a burden that it detracts from developing a quality service and although cessation targets can be helpful, care needs to be taken that they are reasonable and do not promote throughput at the expense of quality.

Entities:  

Mesh:

Year:  2005        PMID: 15755263     DOI: 10.1111/j.1360-0443.2005.01029.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  9 in total

1.  Current Status and Future Prospects of Clinical Psychology: Toward a Scientifically Principled Approach to Mental and Behavioral Health Care.

Authors:  Timothy B Baker; Richard M McFall; Varda Shoham
Journal:  Psychol Sci Public Interest       Date:  2008-11-01

2.  [Proposals for the appropriate organisation of smoking-dependence care and financing its pharmacological treatment].

Authors:  Javier Mataix Sancho
Journal:  Aten Primaria       Date:  2008-08       Impact factor: 1.137

3.  A survey of tobacco dependence treatment guidelines in 31 countries.

Authors:  Martin Raw; Susan Regan; Nancy A Rigotti; Ann McNeill
Journal:  Addiction       Date:  2009-07       Impact factor: 6.526

Review 4.  [Pharmacotherapeutic treatment strategies for smoking cessation].

Authors:  N Vasic; R C Wolf; N Wolf; B J Connemann; Z Sosic-Vasic
Journal:  Nervenarzt       Date:  2011-11       Impact factor: 1.214

Review 5.  A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report.

Authors: 
Journal:  Am J Prev Med       Date:  2008-08       Impact factor: 5.043

Review 6.  The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.

Authors:  Victor U Ekpu; Abraham K Brown
Journal:  Tob Use Insights       Date:  2015-07-14

7.  Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services.

Authors:  Andy McEwen; Robert West
Journal:  BMC Public Health       Date:  2009-01-21       Impact factor: 3.295

8.  The potential to improve ascertainment and intervention to reduce smoking in primary care: a cross sectional survey.

Authors:  Rachael L Murray; Tim Coleman; Marilyn Antoniak; Alexia Fergus; John Britton; Sarah A Lewis
Journal:  BMC Health Serv Res       Date:  2008-01-11       Impact factor: 2.655

9.  "What kind of general practitioner do I need for smoking cessation?" Results from a qualitative study in Poland.

Authors:  Krzysztof Buczkowski; Ludmila Marcinowicz; Slawomir Czachowski; Elwira Piszczek; Agnieszka Sowinska
Journal:  BMC Fam Pract       Date:  2013-10-20       Impact factor: 2.497

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.